Gallacher Capital Management LLC Corcept Therapeutics Inc Transaction History
Gallacher Capital Management LLC
- $205 Billion
- Q1 2025
A detailed history of Gallacher Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Gallacher Capital Management LLC holds 2,498 shares of CORT stock, worth $183,253. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,498Holding current value
$183,253% of portfolio
0.14%Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
476Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.21 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$732 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$568 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$451 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$291 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.86B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...